Biopharma’s AI Fork in the Road

Today's guest post comes from Danny Sigurdson, Founder and CEO at Courier Health.

Danny examines how biopharma companies are approaching patient services, partner changes, and artificial intelligence in 2027. He argues that connected data and purpose-built technology can improve operational efficiency, accelerate access to therapy, and enhance the patient experience.

To learn more, download Courier Health's whitepaper: Patient Experience Innovation in 2027: Lessons from the 3rd Annual Patient Innovators Summit.

Read on for Danny's insights.